SYS ONLINE

Boswellia AKBA-enriched

Standardized AKBA fraction for fast osteoarthritis relief.

Overview

Standardized AKBA fraction for fast osteoarthritis relief.

Natural sources
    Common forms

      Forms & variants of Boswellia

      Different chemical forms of Boswellia behave differently. Browse each form's mechanism, bioavailability, and best-use context.

      Mechanism of action

      Selective 5-LOX inhibition reduces leukotriene-driven joint inflammation.

      Pathways

        Effects on the body

        Organ system effects

        Evidence-based benefits

        Reduces OA pain within 7 days

        Strong evidence

        Potential side effects

        Common
        • · GI upset
        Rare
          Serious

            Drug interactions

            No notable interactions reported.

            Safety & non-supplemental interactions

            Educational summary — always confirm with your clinician or pharmacist before starting, stopping, or combining with prescription therapy.

            Avoid if you are
            • ·Pregnant or breastfeeding (insufficient safety data)
            • ·Children under 18 (unless directed by a clinician)

            Supplement interactions

            Pairs well with

            None listed.

            Avoid combining with

            No specific avoidances listed.

            Dosing & bioavailability

            Typical dose
            100 mg AprèsFlex
            With food?
            With food

            Where to buy

            Affiliate-style search links to reputable retailers. We don't endorse specific brands — verify third-party testing (USP, NSF, Informed Sport) before purchase.

            Scientific evidence (8)

            RCTArthritis Res Ther · 2010

            AprèsFlex in osteoarthritis

            Sengupta K, et al.

            90-day DB-RCT in 60 OA patients.

            Key findings

            Significantly reduced WOMAC pain by day 7 vs placebo.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: Boswellia AKBA-enriched — Reduces OA pain within 7 days

            Live PubMed search

            Live results for "Boswellia AKBA-enriched Reduces OA pain within 7 days" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching Boswellia AKBA-enriched and "Reduces OA pain within 7 days". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: Boswellia AKBA-enriched — randomized controlled trial

            Live PubMed search

            Live results for "Boswellia AKBA-enriched randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching Boswellia AKBA-enriched and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: Boswellia AKBA-enriched — meta-analysis

            Live PubMed search

            Live results for "Boswellia AKBA-enriched meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching Boswellia AKBA-enriched and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: Boswellia AKBA-enriched — pharmacokinetics

            Live PubMed search

            Live results for "Boswellia AKBA-enriched pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching Boswellia AKBA-enriched and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: Boswellia AKBA-enriched — safety adverse events

            Live PubMed search

            Live results for "Boswellia AKBA-enriched safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching Boswellia AKBA-enriched and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: Boswellia AKBA-enriched — dose response

            Live PubMed search

            Live results for "Boswellia AKBA-enriched dose response" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching Boswellia AKBA-enriched and "dose response". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewGoogle Scholar · 1970

            Google Scholar: Boswellia AKBA-enriched — clinical evidence

            Live Scholar search

            Cross-database citation index for Boswellia AKBA-enriched as it relates to "clinical evidence".

            Key findings

            Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

            Open study
            Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.